Wikidata

(Q46577618)

English

Letrozole versus letrozole plus Lapatinib (GW572016) in hormone-sensitive, HER2-negative operable breast cancer: a double-blind, randomized, phase II study with biomarker evaluation (EGF109077-LAP107692/LETLOB).

scientific article published in February 2008

In more languages

Statements

title
Letrozole versus letrozole plus Lapatinib (GW572016) in hormone-sensitive, HER2-negative operable breast cancer: a double-blind, randomized, phase II study with biomarker evaluation (EGF109077-LAP107692/LETLOB) (English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
18501066
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18501066%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 January 2020

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q46577618&oldid=1427335541"